Want to come work in clinical development as a statistics leader in for next generation respiratory assets. Looking for an ambitious and motivated individual to join my team. Despite the job location being US, UK/Remote also considered!
gsk.wd5.myworkdayjobs.com/en…
Our recently published work on Gender differences in CVD morbidity associated with FH, featured in a US-based healthcare professional website, MedPage today
medpagetoday.com/resource-ce…
Our recent paper published in Atherosclerosis, shows that the higher cardiovascular disease risk due to familial hypercholesterolaemia, is higher in women than in men. Available online at doi.org/10.1016/j.atheroscle…. @ATHjournal, Prof Nadeem Qureshi, Prof Joe Kai, @StephenFWeng
Want to work on adaptive trials, phase 0-4, vaccines, new therapies in CVD, oncology and statistical methods. We're expanding in Statistical Decision Sciences. Flex working, great pay, benefits! Get in touch, happy to chat.
jobs.jnj.com/jobs/2005860769…jobs.jnj.com/jobs/2005843470…
Today marks my last day at the University of Nottingham.
It has been a tremendous experience to study, learn and work here, with great support of colleagues through the years.
Grateful for the next opportunity with Janssen J&J as Principal with Statistical Decision Sciences!
thelancet.com/journals/lanpu…
This study is so interesting. Shifts in case definitions over time. Many SEIR models in early phases have relied infection dynamics parameters from Wuhan. Modelling is the art of quantifying uncertainty. Needs careful interpretation
Honoured to be named a co-PI for Covid-19 Open AI Consortium, partnering with OWKIN and Capacity Covid, consortium of >50 centres supplying Covid-19 data.
Link to more info: owkin.com/covid-19/@OWKINscience@MedicineUoN
Introducing the Covid-19 Open AI Consortium! First up: #COAI collaborative research explores Cardiovascular Complications in #COVID19 patients. To researchers, data scientists, & industry players ➡️ let’s join forces to fight this #pandemic. Discover more: owkin.com/covid-19/
(2) Can we predict which Covid-19 patients will have acute cardiac complications including viral myocarditis, type 1 and 2 myocardial infarctions, heart failure, acute coronary syndromes, and arrhythmias?